AG
IONS icon

Aperio Group’s Ionis Pharmaceuticals IONS Stock Holding History

Aperio Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.71M Sell
30,251
-4,886
-14% -$243K 0.01% 1315
2020
Q3 		$1.67M Buy
35,137
+3,866
+12% +$215K 0.01% 1204
2020
Q2 		$1.84M Buy
31,271
+3,741
+14% +$208K 0.01% 1151
2020
Q1 		$1.3M Buy
27,530
+7,454
+37% +$415K 0.01% 1196
2019
Q4 		$1.21M Sell
20,076
-2,459
-11% -$147K ﹤0.01% 1330
2019
Q3 		$1.35M Buy
22,535
+612
+3% +$39.9K 0.01% 1236
2019
Q2 		$1.41M Buy
21,923
+3,279
+18% +$232K 0.01% 1226
2019
Q1 		$1.51M Buy
18,644
+2,864
+18% +$185K 0.01% 1166
2018
Q4 		$853K Sell
15,780
-424
-3% -$21.6K ﹤0.01% 1398
2018
Q3 		$836K Buy
16,204
+1,203
+8% +$56.5K ﹤0.01% 1509
2018
Q2 		$625K Sell
15,001
-2,976
-17% -$132K ﹤0.01% 1643
2018
Q1 		$792K Buy
17,977
+508
+3% +$25.8K ﹤0.01% 1454
2017
Q4 		$879K Sell
17,469
-528
-3% -$29K ﹤0.01% 1382
2017
Q3 		$912K Buy
17,997
+341
+2% +$17.9K 0.01% 1327
2017
Q2 		$898K Buy
17,656
+574
+3% +$26.7K 0.01% 1292
2017
Q1 		$687K Sell
17,082
-1,560
-8% -$70.1K ﹤0.01% 1364
2016
Q4 		$892K Buy
18,642
+6,876
+58% +$272K 0.01% 1188
2016
Q3 		$431K Buy
11,766
+1,479
+14% +$46.3K ﹤0.01% 1534
2016
Q2 		$240K Buy
10,287
+2,982
+41% +$96.2K ﹤0.01% 1765
2016
Q1 		$296K Sell
7,305
-9,516
-57% -$387K ﹤0.01% 1665
2015
Q4 		$1.04M Buy
16,821
+8,667
+106% +$468K 0.01% 996
2015
Q3 		$330K Buy
8,154
+3,789
+87% +$196K ﹤0.01% 1527
2015
Q2 		$251K Buy
4,365
+614
+16% +$39K ﹤0.01% 1738
2015
Q1 		$239K Buy
+3,751
New +$254K ﹤0.01% 1715

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Aperio Group's IONS Position: Q4 2020 in Review

Aperio Group reduced its Ionis Pharmaceuticals (IONS) stake by 14% in Q4 2020, selling an estimated $243K and leaving 30,251 shares worth $1.71M. The position accounts for 0.01% of the portfolio, ranked #1315.

Aperio Group first reported a position in IONS in Q1 2015 and has held it in 24 quarters since. The position peaked at $1.84M in Q2 2020. 383 funds tracked by Wall St. Rank hold IONS as of Q4 2020.

  • Aperio Group held 30,251 shares of Ionis Pharmaceuticals worth $1.71M as of Q4 2020.
  • Aperio Group sold 4,886 Ionis Pharmaceuticals shares in Q4 2020, an estimated $243K.
  • Ionis Pharmaceuticals made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1315 holding.
  • Aperio Group first reported a position in Ionis Pharmaceuticals in Q1 2015 and has held it in 24 quarters since.
  • Aperio Group's Ionis Pharmaceuticals position peaked at $1.84M in Q2 2020.
  • 383 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.